Drug ID: | NPD4344 |
Drug Name: | |
Molecular Formula: | C21H19Cl2N5O2 |
Canonical SMILES: | OCCn1ncc(c1)/C=C/c1[nH]nc2c1cc(cc2)O[C@@H](c1c(Cl)cncc1Cl)C |
Standard InCHI: | InChI=1S/C21H19Cl2N5O2/c1-13(21-17(22)10-24-11-18(21)23)30-15-3-5-20-16(8-15)19(26-27-20)4-2-14-9-25-28(12-14)6-7-29/h2-5,8-13,29H,6-7H2,1H3,(H,26,27)/b4-2+/t13-/m1/s1 |
Standard InCHIKey: | GKJCVYLDJWTWQU-CXLRFSCWSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL003809 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 46944259 |
ChEBI | |
CAS Number |
Molecular Weight | 443.09 |
ALogP | 0.9589 |
MLogP | 2.78 |
XLogP | 3.101 |
HDA | 6 |
HBD | 2 |
Rotatable Bonds | 11 |
TPSA | 88.85 |
RO5 Violation | 0 |